Lsv Asset Management’s United Therapeutics Corp Del Position
Does Lsv Asset Management own United Therapeutics Corp Del (UTHR)? Yes — 398.7K shares worth $236M (+0.51% of its 13F portfolio) as of Q1 2026, down from 408.1K shares the prior filed quarter.
Position Value
$236M
Q1 2026
Shares
398.7K
% of Portfolio
+0.51%
Quarters Held
30
currently held
Position History UTHR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 398.7K | $236M | +0.51% |
| Q4 2025 | 408.1K | $199M | +0.43% |
| Q3 2025 | 686.7K | $288M | +0.64% |
| Q2 2025 | 864.6K | $248M | +0.58% |
| Q1 2025 | 902.3K | $278M | +0.67% |
| Q4 2024 | 908.7K | $321M | +0.74% |
| Q3 2024 | 969.5K | $347M | +0.74% |
| Q2 2024 | 966.4K | $308M | +0.67% |
| Q1 2024 | 529.5K | $122M | +0.25% |
| Q4 2023 | 377.4K | $83M | +0.18% |
| Q3 2023 | 383.1K | $87M | +0.20% |
| Q2 2023 | 379.4K | $84M | +0.18% |
| Q1 2023 | 398.2K | $89M | +0.20% |
| Q4 2022 | 412.0K | $115M | +0.25% |
| Q3 2022 | 565.5K | $118M | +0.28% |
| Q2 2022 | 591.4K | $139M | +0.30% |
| Q1 2022 | 594.4K | $107M | +0.20% |
| Q4 2021 | 537.1K | $116M | +0.21% |
| Q3 2021 | 524.3K | $97M | +0.17% |
| Q2 2021 | 553.6K | $99M | +0.17% |
| Q1 2021 | 573.4K | $96M | +0.16% |
| Q4 2020 | 598.8K | $91M | +0.17% |
| Q3 2020 | 558.0K | $56M | +0.12% |
| Q2 2020 | 518.0K | $63M | +0.13% |
| Q1 2020 | 342.7K | $33M | +0.08% |
| Q4 2019 | 196.4K | $17M | +0.03% |
| Q3 2019 | 128.9K | $10M | +0.02% |
| Q2 2019 | 213.8K | $17M | +0.03% |
| Q1 2019 | 531.2K | $62M | +0.10% |
| Q4 2018 | 616.5K | $67M | +0.12% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lsv Asset Management’s full portfolio or all institutional holders of UTHR.